Reported Earnings • Jul 05
Full year 2026 earnings released: HK$0.066 loss per share (vs HK$0.37 loss in FY 2025) Full year 2026 results: HK$0.066 loss per share (improved from HK$0.37 loss in FY 2025). Revenue: HK$1.43b (up 175% from FY 2025). Net loss: HK$825.3m (loss narrowed 51% from FY 2025). Revenue is expected to fall by 82% p.a. on average during the next 2 years compared to a 11% decline forecast for the Real Estate industry in Germany. Over the last 3 years on average, earnings per share has fallen by 55% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings. New Risk • Jun 29
New major risk - Revenue and earnings growth Earnings have declined by 72% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (5.4% operating cash flow to total debt). Earnings have declined by 72% per year over the past 5 years. 공고 • Jun 29
CSI Properties Limited, Annual General Meeting, Aug 27, 2026 CSI Properties Limited, Annual General Meeting, Aug 27, 2026. 공고 • Jun 17
CSI Properties Limited to Report Fiscal Year 2026 Final Results on Jun 29, 2026 CSI Properties Limited announced that they will report fiscal year 2026 final results on Jun 29, 2026 Board Change • May 21
Less than half of directors are independent Following the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 8 non-independent directors. Independent Non-Executive Director Kevin Yip was the last independent director to join the board, commencing their role in 2025. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. 공고 • Nov 28
CSI Properties Limited Appoints Yip Ka Kay as Independent Non-Executive Director and Member of the Nomination Committee, with Effect from 27 November 2025 The board of directors of CSI Properties Limited announced that Mr. Yip Ka Kay (‘Mr. Yip’) has been appointed as an independent non-executive Director and a member of the nomination committee of the Company (the ‘Nomination Committee’), all with effect from 27 November 2025. Mr. Yip, aged 61, is the managing director and responsible officer of GRE Investment Advisors Limited, a Hong Kong Securities and Futures Commission licensed advisor to NM Strategic Management, LLC and licensed manager to QLA Investment GP SÀRL. Mr. Yip is also an independent non-executive director of Shun Tak Holdings Limited (listed on the Main Board of The Stock Exchange of Hong Kong Limited and a non-executive director of VCREDIT Holdings Limited. Mr. Yip has extensive experience in private equity, alternative and portfolio investment. He was previously the managing director and responsible officer of Bosera Asset Management (International) Co., Limited in Hong Kong. Prior to that, he was a founding and senior partner of General Enterprise Management Services (HK) Limited, a private equity management company. He was also previously a vice president of JP Morgan International Capital Corporation. Mr. Yip is currently a member of the Investment Advisory Committee of EQT Partners, a leading private equity group in Europe, which works with portfolio companies to achieve sustainable growth, operational excellence and market leadership. Mr. Yip holds an A.B. Degree in Economics (magna cum laude) from Harvard University, and is currently a member of Dean's Asia Advisory Committee of Harvard University's Faculty of Arts and Sciences. He sits as a non-scientific member of the Institutional Review Board of the University of Hong Kong/Hospital Authority Hong Kong West Cluster and is a member of the Routine and Expedited Panel of the Hospital Authority Central Institutional Review Board. He was chairman emeritus of the Hong Kong Venture Capital and Private Equity Association. He had also served on the Financial Services Advisory Committee of the Trade Development Council of the Hong Kong Special Administrative Region of the People's Republic of China. Reference is made to the announcement of the Company dated 28 August 2025 in relation to, among others, the non-compliance with Rules 3.10A and 3.27A of the Listing Rules. Following the appointment of Mr. Yip as an independent non-executive Director and a member of the Nomination Committee with effect from 27 November 2025: the Company has eleven Directors, four of whom are independent non-executive Directors, accordingly, the Company is in compliance with the requirements of Rule 3.10A of the Listing Rules; and the Nomination Committee comprises a majority of independent non-executive Directors, accordingly, the Company is in compliance with the requirements of Rule 3.27A of the Listing Rules. 
